Search Results

February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder "Jan 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled

of the New Center of Excellence for Structural Cell Biology Monash Scholars Ranked in Global Top 1% Septerna 2 Clinical Study of GPR65 Inhibitor PTT-4256 in Patients with Advanced Solid Cancers GPCR drugmaker Septerna

commercial R&D executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan Septerna landscape The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 Septerna

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

Classified GPCR News Let’s dive into the Classified GPCR News from February 17th to 23rd, 2025 Industry News Septerna Structural Biologist - Confo Therapeutics Associate Director/Director, Platform & Hit-ID Chemistry Lead - Septerna